All media news

Media
Shepparton becoming epicentre for plant-based medicine production  Read More
September 14, 2023
Media
Cannatrek’s Shepparton facility secures GMP accreditation, boosting export opportunities and local jobs  Read More
September 14, 2023
Media
Cannatrek awarded GMP accreditation for Victorian facility  Read More
September 7, 2023
Media
Cannatrek’s Shepparton facility cultivation milestone  Read More
September 7, 2023
Media
Project places Shepparton at the forefront of plant-based medicine production and distribution  Read More
September 7, 2023
Media
Cannatrek’s Shepparton facility achieves GMP accreditation  Read More
September 7, 2023
Media
International pharmaceutical manufacturing accreditation primes Australian plant-based medicine company for accelerated growth and market leadership Read More
September 5, 2023
Government
New Zealand revamps plant-based medicine regulations to boost industry and research  Read More
July 31, 2023
Industry
Ukraine takes major step towards plant-based medicine legalisation  Read More
July 18, 2023
Industry
Germany paves the way for plant-based medicine legalisation with transformative draft bill  Read More
July 10, 2023
Media
Findings from our recent study with CSIRO released Read More
July 1, 2023
Media
How Cannatrek is deploying innovation in Australia’s evolving plant-based medicine market  Read More
May 28, 2023
Media
Cannatrek shortlisted as finalist in Cannabiz Awards  Read More
May 28, 2023
Media
The Cannatrek Foundation launches to provide support for veterans and first responders Read More
April 25, 2023
Media
Australia, Japan and Thailand: The Green Triangle Read More
March 6, 2023
Media
A boost for agriculture jobs and training Read More
March 3, 2023
Media
Creating a corner of the field for the patient Read More
February 26, 2023
Media
Major project status an export booster for Cannatrek’s $160 million Shepparton plant-based medicine production facility Read More
February 14, 2023
Media
Cannatrek secures CBA debt facility for state-of-the-art plant-based medicine supply chain in regional Victoria Read More
July 2, 2022
Media
Cannatrek completes capital raise to fund continued growth Read More
May 13, 2022
Media
Cannatrek to create hundreds of local jobs through a green energy powered medicinal cannabis facility in Shepparton, Victoria Read More
April 14, 2022
Media
Cannatrek enters strategic research partnership with Canadian-based Strainprint® Technologies, launching myTrek app into Australia. Read More
December 15, 2021
Media
Cannatrek supports Murdoch Children’s Research Institute’s Medicinal Cannabis Research Program for children Read More
August 12, 2021
Media
Cannatrek signs medicinal cannabis strategic partnership agreement with Chemist Warehouse Read More
February 2, 2021
Media
Cannatrek to supply medicinal cannabis products to LYPHE Group to support Project TWENTY21 Read More
January 13, 2021
Media
Cannatrek to export medicinal cannabis to Germany-based Nimbus Health, becoming a key supplier to Europe’s biggest market Read More
December 2, 2020
Media
Seach Medical Group is leading the Israeli export with a first of its kind commercial export to Cannatrek Read More
November 24, 2020
Media
Cannatrek to raise $2.5 million via OnMarket to rollout its national digital telehealth platform Read More
October 24, 2020
Media
Cannatrek releases first products in Australia and secures valuable export agreement with LYPHE Group in the UK Read More
October 12, 2020
Media
Clever Leaves enters Australian market through supply agreement with Cannatrek Read More
August 11, 2020
Media
Cannatrek leads Australian symposium of medicinal cannabis research Read More
July 5, 2020
Media
Cannatrek signs medicinal cannabis production deal with THC Global Read More
June 15, 2020
Media
Cannatrek and RYAH Medtech Inc. to provide Australian patients with dose-measuring inhalers and cartridges Read More
June 9, 2020
Media
Cannatrek signs landmark deal with iX Biopharma’s subsidiary to distribute medicinal cannabis via novel sublingual wafer Read More
April 29, 2020
Media
Cannatrek receives green light to begin growing medicinal cannabis at its Queensland facility Read More
September 15, 2019
Media
Cannatrek to build one of the world’s largest medicinal cannabis facilities in regional Victoria Read More
August 22, 2019
Media
Victorian government announces endorsement for Cannatrek’s development project Read More
January 28, 2019
Media
Cannatrek ships first batch of medicinal cannabis products to Australian patients Read More
November 26, 2018
Media
Cannatrek secures $6.4 million investment with CannTrust as its strategic partner Read More
October 29, 2018
Media
CannTrust expands global reach and access to Asia-Pacific region as Cannatrek’s cornerstone investor Read More
October 28, 2018

Careers

We grow people too.
Check out our current advertised positions.

See full listings

Media
stay informed

We believe everyone has the right to quality healthcare, regardless of circumstances.


We’re committed to making plant-based
medicines affordable and accessible for all.







While research into the efficacy and effects of plant-based medicines, including medicinal cannabis, for certain treatments is increasing, it is currently in its early days. Patients should always talk to a health professional for advice on their unique requirements before making any decisions about treatment options. For the latest, most accurate information on medicinal cannabis, head to the TGA website: https://www.tga.gov.au/medicinal-cannabis-guidance-documents

Address:
PO Box 21 Balaclava 3183 VIC Australia

Contact:
1300 122 662
info@cannatrek.com

Cannatrek acknowledges the Traditional Owners and Custodians of the land on which we work and live, and recognises their continuing connection to land, water and community. We pay our respects to their Elders past, present and emerging.

Investors
Sitemap

Copyright ©2023 Cannatrek

Privacy policy

Terms of service